SCHEMBL9717979

SCHEMBL9717979

CCc1ccccc1NC(=O)Nc1ccccc1CC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.72
KMT2A Q03164 5/20 0.70
MEN1 O00255 4/20 0.70
GAA P10253 2/20 0.70
POLB P06746 3/20 0.69
MAPT P10636 4/20 0.68
PKM P14618 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
TAS1R3 Q7RTX0 1/20 0.67
TAS1R1 Q7RTX1 1/20 0.67
ALDH1A1 P00352 4/20 0.63
HDAC3 O15379 1/20 0.59
HDAC4 P56524 1/20 0.59
HDAC1 Q13547 1/20 0.59
HDAC7 Q8WUI4 1/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC10 Q969S8 1/20 0.59
HDAC11 Q96DB2 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29580443 1.00 HTT (0.72) HTTKMT2AMEN1GAAPOLB
SCHEMBL11028218 0.91 HTT (0.77) HTTKMT2AMEN1GAAPOLB
SCHEMBL948318 0.87 MAPT (0.59) HTTKMT2AMEN1GAAPOLB
SCHEMBL2349955 0.87 MAPT (0.61) HTTKMT2AMEN1GAAPOLB
SCHEMBL5853228 0.86 HTT (0.75) HTTKMT2AMEN1GAAPOLB
SCHEMBL15093807 0.86 POLB (0.58) HTTKMT2AMEN1GAAPOLB
SCHEMBL29580855 0.86 POLB (0.58) HTTKMT2AMEN1GAAPOLB
SCHEMBL13469120 0.86 L3MBTL1 (0.70) HTTKMT2AMEN1GAAPOLB
SCHEMBL8404776 0.85 POLB (0.70) HTTKMT2AMEN1GAAPOLB
Hydrochloric Acid SCHEMBL22346017 0.85 MAPT (0.58) HTTKMT2AMEN1GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
EP-2679575-B1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS ASAHI CHEMICAL IND (JP) 2019-04-10 EP disclosed
CN-103097348-B The manufacture method of carbonyl compound ASAHI KASEI CHEMICALS CORP. (JP) 2015-10-14 CN disclosed
US-8957241-B2 Method for producing carbonyl compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-02-17 US disclosed
US-20130178645-A1 Method for Producing Carbonyl Compund ASAHI KASEI CHEMICALS CORPORATION (JP) 2013-07-11 US disclosed
CN-103097348-A Process for producing carbonyl compounds ASAHI KASEI CHEMICALS CORP (JP) 2013-05-08 CN disclosed
US-5106919-A Acrylic polymers of acids or esters imidized by an N-aryl amide, sulfonamide or urea; high glass transition temperatures MOUNTEDIPE S.R.L. (IT) 1992-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178645-A1 Method for Producing Carbonyl Compund CA6, CPS1, C9 HTT 2396/4885KMT2A 2632/4885MEN1 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.